Invacare Total Assets 2010-2023 | IVCRQ

Invacare total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
Invacare Annual Total Assets
(Millions of US $)
2022 $771
2021 $910
2020 $946
2019 $852
2018 $886
2017 $1,066
2016 $904
2015 $838
2014 $964
2013 $1,096
2012 $1,262
2011 $1,281
2010 $1,280
2009 $1,360
Invacare Quarterly Total Assets
(Millions of US $)
2023-03-31 $762
2022-12-31 $771
2022-09-30 $758
2022-06-30 $813
2022-03-31 $867
2021-12-31 $910
2021-09-30 $922
2021-06-30 $974
2021-03-31 $936
2020-12-31 $946
2020-09-30 $944
2020-06-30 $886
2020-03-31 $869
2019-12-31 $852
2019-09-30 $847
2019-06-30 $868
2019-03-31 $905
2018-12-31 $886
2018-09-30 $963
2018-06-30 $1,030
2018-03-31 $1,067
2017-12-31 $1,066
2017-09-30 $1,055
2017-06-30 $1,018
2017-03-31 $869
2016-12-31 $904
2016-09-30 $951
2016-06-30 $973
2016-03-31 $982
2015-12-31 $838
2015-09-30 $865
2015-06-30 $891
2015-03-31 $886
2014-12-31 $964
2014-09-30 $1,024
2014-06-30 $1,080
2014-03-31 $1,096
2013-12-31 $1,096
2013-09-30 $1,091
2013-06-30 $1,122
2013-03-31 $1,145
2012-12-31 $1,262
2012-09-30 $1,266
2012-06-30 $1,252
2012-03-31 $1,301
2011-12-31 $1,281
2011-09-30 $1,396
2011-06-30 $1,362
2011-03-31 $1,304
2010-12-31 $1,280
2010-09-30 $1,263
2010-06-30 $1,223
2010-03-31 $1,274
2009-12-31 $1,360
2009-09-30 $1,342
2009-06-30 $1,357
2009-03-31 $1,288
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47